Cardlytics (CDLX) AI Stock Analysis

• Market Cap: $59.63M
• Dividend Yield: N/A
• Average Volume (3M): 1.41M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.27
• Revenue Growth: -12.84%
• EPS Growth: 5.09%
• Country: US
• Employees: 440
• Sector: Communication Services
• Sector Strength: 97
• Industry: Advertising Agencies
• EPS (TTM): -0.18
• Shares Outstanding: 53,236,900
• 10 Day Avg. Volume: 1,237,204
• 30 Day Avg. Volume: 1,409,370
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 4.37
• Enterprise Value/Revenue: 0.98
• Enterprise Value/Gross Profit: 2.24
• Enterprise Value/Ebitda: -1.78
• 1Y Price Target: $1.67
• Price Target Upside: 49.11% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4

• Rating: 38 Underperform
• Price Target: $1.00 ▼(-10.71% Downside)

Cardlytics' overall stock score is driven by significant financial challenges and bearish technical indicators. The company's negative profitability, high leverage, and cash flow issues are major concerns. Additionally, the stock's technical indicators suggest ongoing downward momentum. Valuation metrics further highlight unprofitability, contributing to a low overall score.

Positive Factors

Partnership Expansion

Extending the agreement with JPMorgan Chase until 2028 strengthens Cardlytics' strategic partnerships, providing a stable revenue stream and enhancing its market position.

Platform Growth

Rippl's revenue growth and new partnerships indicate successful platform expansion, enhancing Cardlytics' competitive edge and market reach.

High Contribution Margin

A high contribution margin reflects operational efficiency and profitability potential, supporting Cardlytics' long-term financial health.

Negative Factors

Content Restrictions Impact

Content restrictions from a major financial institution partner limit Cardlytics' business operations, impacting billings and revenue negatively.

Revenue Decline

A decline in revenue indicates challenges in maintaining growth and market competitiveness, potentially affecting long-term financial stability.

High Leverage

High leverage poses financial risk, limiting flexibility and increasing vulnerability to economic fluctuations, impacting Cardlytics' long-term viability.

Cardlytics Business Overview & Revenue Model

Company Description

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

How the Company Makes Money

Cardlytics generates revenue primarily through a performance-based advertising model. The company's main revenue streams include: 1) Advertising Fees: Cardlytics earns fees from advertisers based on the performance of their campaigns, typically measured by the number of transactions generated from the offers presented to consumers. This performance-based model aligns the company's interests with those of its clients, as it is compensated when consumers engage with offers and make purchases. 2) Partnerships with Financial Institutions: The company has formed strategic partnerships with various banks and credit unions, which serve as distribution channels for its marketing solutions. These partnerships allow Cardlytics to access a large consumer base and enhance the effectiveness of its advertising campaigns. 3) Data Insights: Cardlytics also monetizes its extensive purchase data by providing insights and analytics to advertisers about consumer behavior and trends, which helps them optimize their marketing strategies. Overall, the combination of performance-based fees, strategic partnerships, and data-driven insights contributes significantly to Cardlytics' revenue generation.

Cardlytics Financial Statement Overview

Summary

Cardlytics is facing considerable financial challenges with declining revenues and persistent losses. High leverage and negative equity returns highlight the financial risk. Despite some improvements in operating cash flow, the company needs to address profitability issues and manage its debt more effectively to improve its financial health.

Income Statement

Cardlytics has experienced declining revenue over the recent period, with a revenue decrease of 2.05% from the previous year. The company's gross profit margin remains relatively stable at 42.68% for TTM (Trailing-Twelve-Months), but net profit margin is significantly negative at -65.43%, indicating ongoing challenges in achieving profitability. EBIT and EBITDA margins are also negative, highlighting operational inefficiencies.

Balance Sheet

The company exhibits a high debt-to-equity ratio of 3.44, indicating significant leverage and potential risk if revenues continue to decline. Return on equity is negative at -278.25% due to ongoing net losses. The equity ratio is low at 17.36%, suggesting limited equity cushion and a reliance on liabilities for financing.

Cash Flow

While Cardlytics has managed to improve its operating cash flow, turning positive in the TTM period, free cash flow remains negative. The free cash flow to net income ratio is low, indicating limited conversion of accounting profits to cash. The operating cash flow to net income ratio is positive but reflects the company's struggle to generate cash consistently.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	266.20M	278.30M	309.20M	298.54M	267.12M	186.89M
Gross Profit	116.32M	120.89M	130.38M	112.63M	103.34M	63.27M
EBITDA	-146.64M	-152.53M	-99.00M	-418.98M	-89.91M	-39.51M
Net Income	-183.34M	-189.30M	-134.70M	-465.26M	-128.56M	-58.47M
Balance Sheet
Total Assets	361.13M	392.71M	574.14M	691.24M	1.26B	422.54M
Cash, Cash Equivalents and Short-Term Investments	46.74M	65.59M	91.83M	121.91M	233.47M	293.24M
Total Debt	220.41M	221.65M	266.11M	235.26M	197.23M	188.12M
Total Liabilities	302.43M	322.72M	439.35M	479.63M	573.10M	265.35M
Stockholders Equity	58.71M	69.99M	134.80M	211.60M	690.70M	157.19M
Cash Flow
Free Cash Flow	-10.81M	-28.12M	-12.58M	-67.39M	-51.09M	-17.71M
Operating Cash Flow	-1.12M	-8.82M	-185.00K	-53.90M	-38.52M	-7.60M
Investing Cash Flow	-17.90M	-18.75M	-10.06M	-15.76M	-506.69M	-10.12M
Financing Cash Flow	-5.68M	1.44M	-20.03M	-39.99M	486.00M	206.43M

Cardlytics Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CDLX, the sentiment is Neutral. The current price of 1.12 is above the 20-day moving average (MA) of 1.03, below the 50-day MA of 1.53, and below the 200-day MA of 2.29, indicating a neutral trend. The MACD of -0.13 indicates Negative momentum. The RSI at 46.88 is Neutral, neither overbought nor oversold. The STOCH value of 70.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CDLX.

Cardlytics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DLX	71 Outperform	$880.65M	15.28	9.20%	6.12%	-1.92%	49.63%
Sector *	60 Neutral	$47.40B	4.51	-11.27%	4.14%	2.83%	-41.62%
TSQ	55 Neutral	$115.28M	3.48	74.55%	11.34%	-0.11%	―
MCHX	46 Neutral	$86.37M	―	-13.93%	―	-2.64%	6.48%
FLNT	45 Neutral	$49.02M	―	-115.36%	―	-12.84%	63.95%
INUV	44 Neutral	$50.06M	―	-36.41%	―	21.45%	41.21%
CDLX	38 Underperform	$59.63M	―	-136.44%	―	-12.84%	5.09%

Cardlytics Corporate Events

Cardlytics Extends Agreement with JPMorgan Chase

On July 7, 2025, Cardlytics, Inc. announced the extension of its Master Agreement with JPMorgan Chase Bank until November 18, 2028, through a Fourth Amendment. This amendment includes changes to Supplier Billings Share, Incentive Bonus, and Quality Credits, with a notable reduction in Supplier Billings Share starting January 1, 2026, although it remains higher than the level before the Third Amendment.